Latest news

Fox Business: Interview with Chief Market Strategist, Lou Basenese

Fox Business: Interview with CEO Michael Heltzen

Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

Watch eXoZymes' Nasdaq closing bell ceremony

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering on Feb 19, 2025

Nasdaq Bell Ringing to Commemorate Initial Public Offering

GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes

Creating value for partners through exozyme biosolutions

The difference between enzymes and exozymes: Explaining our tech

Vision: What's the potential impact of exozymes?

eXoZymes signifiy a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes